
How can psychedelic research incorporate disability inclusion into future work?

How can psychedelic research incorporate disability inclusion into future work?

What are your thoughts on psychedelics?

What's the latest update on cannabis legislation and its clinical utility?

Research is underway to make psychedelics agents a treatment option for psychiatric disorders.

Drug comparison has significant implications for dose- and substance-dependence.

Welcome to the psychedelic renaissance.

Is cannabis’ effect on schizophrenia being downplayed?

Psychedelics: returning hope to veterans with PTSD.

Here's why psychedelics might be a valuable addition to mental health treatment.

What does the movie Dune say about our society’s current relationship with psychedelics?

Scare tactics don’t work. But scientific education might. Here are tips for talking with teenaged patients about keeping themselves and their friends safe.

A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.

10 keys to understanding the science of cannabinoids.

Timothy W. Fong, MD, touches on our current understanding about cannabis use for psychiatric disorders.

Research on psilocybin, LSD, and other hallucinogens as psychiatric treatments are in their renaissance, transitioning from banned and illegal to potentially useful in changing life for the better in some patients. More in this podcast.

Research on psychiatrists' attitudes on the potential of cannabis in psychiatry.

Enlightening survey results reveal what psychiatrists think about medical marijuana/cannabis use, how or whether to discuss with their patients, and what biases might get in the way of such conversations.

The sharply decreasing perception of risk and easy accessibility of cannabis has many patients turning towards it, despite the potential negative effects.

Cannabis use has prompted symptoms such as dizziness, sleepiness, and fatigue in older patients. Are there any benevolent effects?

The rapidly changing field of cannabinoids and their clinical implications poses a particular challenge in psychiatry.

Early studies find psilocybin shows promise for some psychiatric disorders...

A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.

The conversation about cannabis is happening now.

Research on a new kind of cannabis treatment prepares to move forward.

What are your thought about navigating these uncharted waters?